SCHEMBL7975240

SCHEMBL7975240

Cc1cccc(Cn2cnc3nc(-c4cccc(Cl)c4)nc(O)c32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GLA P06280 1/20 0.41
UBE2N P61088 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 4/20 0.40
TSHR P16473 3/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
TP53 P04637 1/20 0.40
BRD4 O60885 1/20 0.39
YTHDC1 Q96MU7 2/20 0.39
LMNA P02545 3/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973626 0.92 SMN1; SMN2 (0.45) CYP11B1CYP11B2HTTSMN1; SMN2GLA
SCHEMBL7991597 0.92 PDE4B (0.39) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL7974012 0.90 ALDH1A1 (0.41) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL7974247 0.89 CYP11B1 (0.44) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL7988594 0.89 TP53 (0.44) ALDH1A1CYP11B1CYP11B2SMN1; SMN2L3MBTL1
SCHEMBL7974268 0.89 CYP11B1 (0.48) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL7991557 0.88 LMNA (0.43) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL7988958 0.88 ALDH1A1 (0.42) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL7985360 0.88 POLB (0.40) HTTSMN1; SMN2GLAUBE2NL3MBTL1
SCHEMBL7991646 0.87 SMN1; SMN2 (0.43) HTTSMN1; SMN2GLAUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed